NASDAQ:FHTX | Free Cash Flow | Foghorn Therapeutics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$25.27M$0.00-$25.27M
2025-12-31-$22.27M$0.00-$22.27M
2025-03-31-$23.97M$28,000.00-$24M
2024-12-31-$24.52M$479,000.00-$25M
2024-03-31-$29.35M$101,000.00-$29.45M
2023-12-31-$27.54M$37,000.00-$27.58M
2023-03-31-$31.18M$636,000.00-$31.82M
2022-12-31-$28.92M$269,000.00-$29.19M
2022-03-31$271.53M$247,000.00$271.29M
2021-12-31$11.88M$80,000.00$11.8M
2021-03-31-$23.15M$1.79M-$24.94M
2020-12-31-$10.66M$7.49M-$18.14M
2020-03-31-$10.76M$1.02M-$11.78M
2019-12-31-$13.18M$128,000.00-$13.31M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$86.1M$50,000.00-$86.15M
2024-12-31-$100.41M$906,000.00-$101.31M
2023-12-31-$118.11M$1.22M-$119.33M
2022-12-31$193.61M$1.21M$192.4M
2021-12-31-$50.25M$3.31M-$53.56M
2020-12-31-$31.29M$16.18M-$47.47M
2019-12-31-$46.34M$968,000.00-$47.3M